Ningbo Krka Menovo Pharmaceutical

Ningbo Krka Menovo Pharmaceutical is a strategic joint venture between the Slovenian pharmaceutical company Krka and the Chinese firm Ningbo Menovo Pharmaceutical. Founded in 2017, the company is dedicated to the development, manufacturing, and commercialization of generic pharmaceutical products, specifically finished dosage forms. Its operations are centered in Ningbo, China, where it utilizes advanced manufacturing facilities to produce medications for cardiovascular, gastrointestinal, and central nervous system therapeutic areas. The partnership combines Krka's global pharmaceutical standards and product portfolio with Menovo's local production capacity and market access in China. The company serves both the domestic Chinese market and international markets through its high-quality generic offerings.